AstraZeneca has established the BioHub at Alderley Park to allow bioscience start-ups and growing companies the opportunity to access world-class facilities available at its Alderley Park site. It is a collaborative R&D centre where new and growing bioscience businesses can benefit from the Park's scientific heritage and its state-of the-art research facilities while operating entirely independently. Currently BioHub have 69 companies and 274 staff on site as tenants
